Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-05-04
2010-12-07
Ford, Vanessa L. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S239100, C424S184100, C530S300000
Reexamination Certificate
active
07846457
ABSTRACT:
A method of temporarily elevating the eyebrow position and softening undesirable glabellar muscle activity to affect a more desirable appearance. In a broad aspect the invention comprises injecting small quantities ofbotulinumtoxin (BTX) equivalent in activity to 0.001 to 1.0 Units ofbotulinumtoxin A, dissolved in 10 to 50 microliters microdroplets of injectable saline carrier, and injected 0.5 to 1.0 millimeters below the skin surface to treat the septal and orbital orbicularis oculi muscles, on each side of a patient's face. In sufficient numbers, injected microdroplets of BTX are able to selectively weaken these muscles. This method preferably also includes using microdroplets of BTX to treat: a) the depressor supercilii muscle, on each side; b) the procerus muscle; c) the corrugator supercilii muscle, on each side; and d) the inferior limit of the frontalis muscle where it meets the superior aspect of the orbital portion of the orbicularis oculi muscle.
REFERENCES:
patent: 5401243 (1995-03-01), Borodic
patent: 6358917 (2002-03-01), Carruthers et al.
patent: 6861058 (2005-03-01), Aoki et al.
patent: 2005/0208075 (2005-09-01), Borodic
Ahn et al (Plastic and Reconstructive Surgery, Mar. 2000, p. 1129-1135).
Huilgol et al (Dematol Surg, 25:5 May 1999, p. 373-376).
Heckmann et al (J. Am Acad Dermatol, Published online May 23, 2001, p. 1-7).
A. Scott, A. Rosenbaum, C. Collins (1973) Pharmacologic Weakening of Extraocular Muscles; Invest Ophthalmol. 12:924-7.
P. Savino and M. Maus (1991) Botulinum Toxin Therapy; Neurol. Clin. 9:205-24.
J. Melling, P. Hambleton, C. Shone. (1988)Clostridium botulinumToxins: Nature and Preparation for Clinical Use; Eye 2: 16-23.
J. Carruthers and A. Carruthers (1992) Treatment of Glabellar Frown Lines WithC. botulinum-A Exotoxin; J. Dermatol. Surg. Oncol. 18:17-21.
J. Carruthers and A. Carruthers (2004) Botox: Beyond Wrinkles; Clin. Dermatol. 22:89-93.
A. Karacalar, A. Korkmaz, A. Kale, and C. Kopuz (2005) Compensatory Brow Asymmetry: Anatomic Study and Clinical Experience; Aesthetic Plast. Surg 29: 119-23.
W. Huang, A. Rogachefsky, and J. Foster (2000) Browlift With Botulinum Toxin; Dermatol. Surg. 26:55-60.
S. Teske, et. al. (1998) Hering's Law and Eyebrow Position; Ophthal. Plast. Reconstr. Surg. 14: 105-6.
A. Trindade De Alemeida and S. Cernea (2001) Regarding Browlift With Botulinum Toxin; Dermatol. Surg. 27:848-849.
E. Schantz, D. Kautter (1978) Standardized Assay forClostridium botulinumToxins. J Assoc Anal Chem 61:96-99.
S. Huilgol, A. Carruthers, and J. Carruthers (1999) R Ing Eyebrows With Botulinum Toxin; Dermatol. Surg. 1999: 373-5.
D. Knize (1996) An Anatomically Based Study of the Mechanism of Eyebrow Ptosis; Plastic & Reconstructive Surgery, 97:1-19.
R. Bhidayasiri, D. Truong (2005) Expanding Use of Botulinum Toxin; Journal of Neurological Sciences 235:1-9.
A. Chen, A. Frankel (2003) Altering Brow Contour With Botulinum Toxin; Facial Plastic Surgery Clinics of North America 11:457-464.
Ford Vanessa L.
Ginsberg Lawrence N.
LandOfFree
Cosmetic use of botulinum toxin for the treatment of eyebrow... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosmetic use of botulinum toxin for the treatment of eyebrow..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosmetic use of botulinum toxin for the treatment of eyebrow... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4192804